Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy
All authors: Michal M, Barbora V, Katarina K, Michal P, Zuzana C, Zuzana S, Miroslav C, Natalia U, Lucia K, Peter C.
PLoS One. 2025 Dec 31;20(12):e0340033. doi: 10.1371/journal.pone.0340033. Erratum for: PLoS One. 2025 Dec 4;20(12):e0336190. doi: 10.1371/journal.pone.0336190. PMID: 41474690; PMCID: PMC12755787.